Literature DB >> 21441017

Imaging technologies for high dose rate brachytherapy for cervical cancer: a systematic review.

D D'Souza1, F Baldassarre, G Morton, C Falkson, D Batchelar.   

Abstract

The aim of this overview was to assess the utility of various imaging technologies (fluoroscopy, ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography) for the treatment planning of high dose rate brachytherapy for cervical cancer. Reviews and primary studies comparing different imaging technologies used during high dose rate brachytherapy for cervical cancer and published from 1988 to 2008 were sought by searching MEDLINE and EMBASE databases, the Cochrane Library, personal files and reference lists of identified studies, and by contacting experts. Study selection, study quality assessment and data extraction were carried out in duplicate. Twelve studies met the inclusion criteria. No systematic reviews or randomised controlled studies (RCTs) were located. The validity assessment revealed that the quality of the existing studies is very variable. This is the first systematic review in the area of imaging technologies for cervix brachytherapy. No RCTs have been located and it is possible that an RCT is not the optimal methodology to assess imaging technologies. However, in this area there is a need for more prospective studies and for studies that consider the expertise of the operators in their design. The studies found supported the use of three-dimensional imaging as opposed to the traditional two-dimensional imaging. However, apart from the effectiveness of visualising tumours and surrounding tissues, the utility of imaging technologies in clinical practice is determined by other contextual factors, such as their availability, accessibility and ease of use.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21441017     DOI: 10.1016/j.clon.2011.02.014

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  5 in total

1.  BJR brachytherapy dosimetry special feature.

Authors:  A L Palmer
Journal:  Br J Radiol       Date:  2014-07-23       Impact factor: 3.039

2.  The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer.

Authors:  Jiheon Song; Najlaa Alyamani; Gaurav Bhattacharya; Tien Le; Choan E; Rajiv Samant
Journal:  Adv Radiat Oncol       Date:  2020-02-28

3.  Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques.

Authors:  Antony Palmer; David Bradley; Andrew Nisbet
Journal:  J Contemp Brachytherapy       Date:  2012-06-30

4.  Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer.

Authors:  Yong-Chun Zhou; Li-Na Zhao; Ning Wang; Jing Hu; Xiao-Huan Sun; Ying Zhang; Jian-Ping Li; Wei-Wei Li; Jun-Yue Liu; Li-Chun Wei; Mei Shi
Journal:  Cancer Med       Date:  2016-01-24       Impact factor: 4.452

5.  Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.

Authors:  Alparslan Serarslan; Bilge Gursel; Deniz Meydan; Nilgun Ozbek Okumus
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.